ERBB2 and neoplasm: [68Ga]Ga-ABY-025 is now being investigated for its ability to detect HER2-low metastatic breast cancer at our institution, where patients with HER2-low metastatic breast cancer will undergo one HER2-PET followed by tumor biopsies (NCT05619016).